Search results
Results from the WOW.Com Content Network
E. W. Kemble's "Death's Laboratory" on the cover of the 3 June 1905 edition of Collier's. A patent medicine (sometimes called a proprietary medicine) is a non-prescription medicine or medicinal preparation that is typically protected and advertised by a trademark and trade name, and claimed to be effective against minor disorders and symptoms, [1] [2] [3] as opposed to a prescription drug that ...
A medical patent may refer to a biological patent (see also gene patent) a chemical or pharmaceutical patent; a patent on a medical device; Second medical indication ...
E. W. Kemble's "Death's Laboratory" on the cover of Collier's (June 3, 1905). A patent medicine, also known as a proprietary medicine or a nostrum (from the Latin nostrum remedium, or "our remedy") is a commercial product advertised to consumers as an over-the-counter medicine, generally for a variety of ailments, without regard to its actual effectiveness or the potential for harmful side ...
"The patent internalizes the externality by giving the [inventor] a property right over its invention." [108] In accordance with the original definition of the term "patent", patents are intended to facilitate and encourage disclosure of innovations into the public domain for the common good.
The executives and scientists of big pharma companies are extremely intelligent people. How then, could nearly all of the world's largest pharmaceutical companies have journeyed over the patent cliff?
Capillary blood glucose (British medical colloquialism originating from Boehringer Mannheim, a manufacturer of early glucose meters, today a part of Boehringer Ingelheim.) BMBx: Bone marrow biopsy: BMC: bone mineral content: BMD: bone mineral density (also termed bone mass measurement) BMI: body mass index: BMP: basic metabolic panel: BMR ...
This is a list of abbreviations used in medical prescriptions, including hospital orders (the patient-directed part of which is referred to as sig codes).This list does not include abbreviations for pharmaceuticals or drug name suffixes such as CD, CR, ER, XT (See Time release technology § List of abbreviations for those).
A VL is an agreement where an originator manufacturer allows a generic manufacturer to produce and sell a patented drug in specific countries under certain terms. These licences can be established directly between patent holders and generic manufacturers or through patent pooling mechanisms like the Medicines Patent Pool.